新诊断胶质母细胞瘤切除后放疗启动时机对生存的影响
三组间无进展生存(PFS)与总生存(OS)均无显著差异;放疗启动延迟超过48天者OS显著缩短。结论认为48天内启动放疗不恶化生存,不应延迟也不应强行提前,而应在术后恢复后及时开始。
要点
- 手术至放疗间隔<28天、28-33天、>33天三组间PFS与OS无显著差异。
- 放疗启动延迟超过48天者OS显著缩短(p=0.034)。
- 残留肿瘤体积与中线结构受累是PFS独立预后因素。
核心结论
- 48天内启动放疗与生存恶化无关,但延迟超过48天可能与更差OS相关。
- 放疗不应延迟也不应强行提前,应在患者术后恢复后及时开始。
研究设计与样本
- 按手术至放疗启动间隔分为<28天、28-33天、>33天三组,采用Kaplan-Meier与Cox回归比较PFS和OS。
主要发现
- 三组间PFS无显著差异(p=0.516),OS无显著差异(p=0.902)。
- 残留肿瘤体积与中线结构受累为PFS独立预后因素。
- 年龄、MGMT状态、Ki67指数、残留肿瘤体积与中线结构受累为OS独立预测因素。
- 放疗启动延迟超过48天者OS显著缩短(p=0.034)。
关键数值与推荐
- 手术至放疗启动间隔分组阈值:<28天、28-33天、>33天。
- 延长延迟定义为>48天,该组OS显著更短(p=0.034)。
临床怎么用
- 胶质母细胞瘤术后放疗应在患者恢复后及时启动,无需刻意延迟,也无需强行提前。
- 对预计放疗启动可能超过48天者应关注生存风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: To evaluate the effect of timing of radiotherapy (RT) on survival in patients with newly diagnosed primary glioblastoma (GBM) treated with the same therapeutical protocol. MATERIALS AND METHODS: Patients with newly diagnosed primary GBM treated with the same therapeutical scheme between 2010 and 2015 in our institution were retrospectively reviewed. The population was trichotomized based on the time interval from surgery till initiation of RT (< 28 days, 28-33 days, > 33 days). Kaplan-Meier and Cox regression analyses were used to compare progression free survival (PFS) and overall survival (OS) between the groups. The influence of various extensively studied prognostic factors on survival was assessed by multivariate analysis. RESULTS: One-hundred-fifty-one patients met the inclusion criteria. Between the three groups no significant difference in PFS (p = 0.516) or OS (p = 0.902) could be demonstrated. Residual tumor volume (RTV) and midline structures involvement were identified as independent prognostic factors of PFS while age, O-6-Methylguanine Methyltransferase (MGMT) status, Ki67 index, RTV and midline structures involvement represented independent predictors of OS. Patients starting RT after a prolonged delay (> 48 days) exhibited a significantly shorter OS (p = 0.034). CONCLUSION: Initiation of RT within a timeframe of 48 days is not associated with worsened survival. A prolonged delay (> 48 days) may be associated with worse OS. RT should neither be delayed, nor forced, but should rather start timely, as soon as the patient has recovered from surgery.
引用
- Katsigiannis S, Krischek B, Barleanu S, et al. Impact of time to initiation of radiotherapy on survival after resection of newly diagnosed glioblastoma. Radiat Oncol. 2019. PMID: 31036031. doi:10.1186/s13014-019-1272-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。